Deconstructing Actavis v Eli Lilly

The Supreme Court's decision in Actavis v Eli Lilly [2017] UKSC 48 has changed the way that the UK courts will determine the extent of protection of a patent's claim. Prior to this decision, since the House of Lords' decision in Catnic Components v Hill [1982] RPC 183 the UK courts has used "purposive construction" in order to establish the scope of a patent's claim.

As famously explained by Lord Hoffmann in the seminal decision of the House of Lords in Kirin Amgen v Hoechst Marion Roussel [2005] RPC 9 the crux of purposive construction is to determine "what the person skilled…

Full article available on PatentHub

Latest insights

More Insights
Crowd from above

Setting up a business in France

Jul 31 2025

Read More
Curiosity line yellow background

Hong Kong: A New Chapter in Medical Products Regulations

Jul 30 2025

Read More
featured image

UPC establishes jurisdiction over UK patent rights in landmark decision

5 minutes Jul 29 2025

Read More